Kaken Pharmaceutical

Kaken Pharmaceutical

World Rank (Jan-05-2024)
9,295
Market Cap (Jan-05-2024)
0.876 Billion USD
World Rank (Jul-30-2023)
9,106
Market Cap (Jul-30-2023)
0.929 Billion USD
World Rank (Jan-07-2022)
7,872
Market Cap (Jan-07-2022)
1.360 Billion USD
World Rank (Jan-01-2021)
6,451
Market Cap (Jan-01-2021)
1.482 Billion USD
Headquarters Country
Japan
Market Cap (Mar-08-2026)
1.03
Employee Count
1,268
Employee Count as of Date
As on 2020
World Region
Asia
World Subregion
Eastern Asia
Annual Revenue in USD
555 Million USD
Annual Net Income in USD
70 Million USD
Annual Results for Period Ending
Mar-2022 ending year
Total Assets in USD
1,205 Million USD
Total Liabilities in USD
196 Million USD
Total Equity in USD
1,009 Million USD
Balance Sheet for Period Ending
Mar-2022 ending year
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Company Website
KAKEN PHARMACEUTICAL
Yahoo
Yahoo @ Tokyo
Company Profile
Kaken Pharmaceutical is a specialty pharmaceutical company with strong experience in developing and commercializing novel pharmaceuticals and medical devices in the fields of orthopaedics and dermatology. The company annual revenue is 76,034 million JPY and annual net income is 9,549 million JPY for year ending March 2022. The headquarters is in Japan.
Stock Exchange
Tokyo

Share